Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus dexmedetomidine for prevention of emergence delirium after pediatric tonsillectomy/adenoidectomy
ChiCTR2600132012Phase 4Not yet recruiting
- Sponsor
- Affiliated Women and Children's Hospital of Ningbo University
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remimazolam, dexmedetomidine and Normal Saline-Benha University in Emergence agitation (EA) (3 arms), sponsored by Affiliated Women and Children's Hospital of Ningbo University. Primary endpoint: Incidence of emergence delirium during recovery. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
remimazolamdexmedetomidineNormal Saline-Benha University
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2600132012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132012.